Home › Arena: Belviq Scripts See Modest Rise, Revenue Story Not Promising
 

Keywords :   


Arena: Belviq Scripts See Modest Rise, Revenue Story Not Promising

2015-03-21 10:01:41| Biotech - Topix.net

While many Arena investors would like to see a pretty picture painted about the sales of Belviq, the fact of the matter is that script sales are not hitting the type of growth that is needed to drive the equity. In addition, with a price cut, the revenue story is not what is needed either.

Tags: story rise revenue scripts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05IMDA launches annual IMDA Awards Competition
20.05Registration opens for FTAs Fall Technical Conference 2024
20.05Voting begins for Colored By INX Can Design Contest
20.05New Study Highlights Biodegradability of Cotton and Cellulosic Microfibers
20.05New ACA-Published Industry Market Analysis for the Paint & Coatings Industry Now Available
20.05Ulta Beauty Launches Same-Day Delivery with DoorDash
20.05Nivea Crmes Limited-Edition Pride Tin Heralds New Initiative with PFLAG
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
More »